News | Cardiac Imaging | February 12, 2024

Free-breathing DL vs. Breath-hold Cardiac MRI Sequences in Ischemic Heart Disease

85-year-old patient with ischemic heart disease, who underwent cardiac MRI at 3 T

85-year-old patient with ischemic heart disease, who underwent cardiac MRI at 3 T.

A. Short-axis image from standard cine balanced SSFP breath-hold sequence.

B. Short-axis image from free-breathing accelerated cine sequence with deep-learning reconstruction. Images show normal appearance of left ventricular myocardium.


February 12, 2024 — According to the American Journal of Roentgenology (AJR), free-breathing cine-deep learning (DL) may yield reliable left ventricular ejection fraction (LVEF) measurements in patients with ischemic heart disease (IHD) unable to repeatedly breath-hold.

“Free-breathing cine-DL sequence, in comparison with standard breath-hold cine sequence, showed very small bias for LVEF measurements and better subjective quality,” wrote David Monteuuis, MD, from the department of radiology at Amiens University Hospital in France. “Cine-DL yielded greater left ventricular volumes.”

David et al.’s AJR accepted manuscript included patients undergoing 1.5-T or 3-T cardiac MRI for evaluation of IHD (March 15–June 21, 2023). Examinations included an investigational free-breathing cine short-axis sequence with DL reconstruction (cine-DL). In blinded fashion, two radiologists (R1, R2) independently assessed LVEF, left ventricular end-diastolic volume (LVEDV), left ventricular end-systolic volume (LVESV), and subjective image quality, for cine-DL sequence and standard breath-hold balanced SSFP sequences; R1 assessed artifacts.

Ultimately, in patients with IHD, the free-breathing cine sequence with DL reconstruction showed very low bias for LVEFmeasurements (R1: 0.4%; R2: 0.7%) and better subjective image quality (R1: 2.3±0.5 vs 1.9±0.8; R2: 2.2±0.4 vs 1.9±0.7) in shorter acquisition times (0.6±0.1 vs 2.4±0.6 min).

“This free-breathing cine-DL sequence could be particularly useful in the evaluation of patients with dyspnea who are unable to perform repeated breath-holds,” the AJR authors added.

For more information: www.arrs.or


Related Content

News | Cardiac Imaging

March 18, 2026 — Circle Cardiovascular Imaging (Circle CVI) has announced the expansion of its cvi42 cardiovascular ...

Home March 20, 2026
Home
News | Cardiac Imaging

March 19, 2026 — Heart disease is the leading cause of adult death worldwide, making cardiovascular disease diagnosis ...

Home March 20, 2026
Home
News | Cardiac Imaging

March 16, 2026 — The American Society for Preventive Cardiology (ASPC) will host its 2026 Virtual Imaging Symposium, a ...

Home March 17, 2026
Home
Feature | Cardiac Imaging

Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...

Home March 13, 2026
Home
News | Cardiac Imaging

March 6, 2026 — Building on its leadership in cardiac MR, Philips has received FDA 510(k) clearance for SmartHeart, an ...

Home March 09, 2026
Home
News | Cardiac Imaging

Feb. 26, 2026 — The U.S. Food and Drug Administration (FDA) has given 510(k) class II clearance of qXR-Detect, the ...

Home February 26, 2026
Home
News | Cardiac Imaging

Feb. 13, 2026 — Conavi Medical Corp. recently highlighted the publication of new peer-reviewed research titled “Deep ...

Home February 16, 2026
Home
News | Cardiac Imaging

Jan. 27. 2026 — Circle Cardiovascular Imaging Inc. has announced the release of cvi42 v6.4, the latest version of its ...

Home January 28, 2026
Home
News | Cardiac Imaging

Jan. 6, 2026 — UltraSight, a provider of AI-guided cardiac imaging workflows, has announced FDA clearance to expand its ...

Home January 16, 2026
Home
News | Cardiac Imaging

Jan. 12, 2026 — YorLabs, Inc., a medical technology company providing next-generation intracardiac imaging solutions for ...

Home January 13, 2026
Home
Subscribe Now